A study for evaluating the effect of the intake of the Jerusalem artichoke supplement on postprandial hyperglycemia

A study for evaluating the effect of the intake of the Jerusalem artichoke supplement on postprandial hyperglycemia : a double-blind, randomized placebo-controlled and parallel study - Trial for food containing Jerusalem artichoke

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038317

Enrollment

Registered

2019-10-18

Start date

2019-11-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingest Jerusalem artichoke supplement(for 12 weeks) Ingest placebo (for 12 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects whose fasting blood glucose levels are less than 126 mg/dL. 2. Subjects whose postprandial blood glucose levels 2 hours after OGTT are less than 199 mg/dL.

Exclusion criteria

Exclusion criteria: 1. Subjects with food allergies 2. Subjects who are pregnant or lactating 3. Subjects who consume medicinal product which may influence the outcome of the study 4.Subjects who consume food which may influence the outcome of the study 5. Subjects who are judged as unsuitable for the study by the investigator for the other reason

Design outcomes

Primary

Measure	Time frame
Postprandial blood glucose, AUC	—

Secondary

Measure	Time frame
fasting plasma glucose, HbA1c, neutral fat	—

Countries

Japan

Contacts

Public ContactTakeshi Kaneko

Japan Clinical Trial Association N.A.

info@yakujihou.org0364574666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026